MYM's Great Financials Show Why They Shouldn't Sell Out In light of MYM Nutraceuticals' great financial performance, including a major EBITDA improvement from same quarter last year from a negative to a positive, and also start generating good cash flow, now you know why it's a bad idea for them to sell out to IM Cannabis.
However, MYM Nutraceuticals needs to work on their Calendar Literacy as they considered the previous quarter as "Quarter 3 2021".
Technically speaking, a 3rd quarter is July 1 - September 30, not December 1 - February 28.
With MYM showing great improvements in their financial statements, they are better off remaining as their own company as opposed to being in the hands of IM Cannabis.